CBD

EXCLUSIVE: DoorDash Reveals Why It's Betting On THC, CBD Delivery
This Week In Cannabis: Rescheduling Delays, The DEA, Biden's Clemency, Philip Morris' New Bet And More
Cannabis In 2025: Inside America's Social, Economic, Wellness Transformation
This Week In Cannabis: Rescheduling Delays, The DEA, Biden's Clemency, Philip Morris' New Bet And More
Cannabis In 2025: Inside America's Social, Economic, Wellness Transformation
Will Hemp Clothing Ever Become Affordable? Here's What's Changing
Beyond The CBD Bubble: Can Hemp Fiber Boost US Manufacturing With Eco-Friendly Products?

CBD Recent News

Rescheduling Cannabis Could Allow For Hemp Tobacco Cigarettes, But Not Weed And Tobacco Mixtures: No Spliff For You!
This article was originally published on Cannabis.net and appears here with permission. Marijuana rescheduling could permit CBD from hemp in tobacco, but not weed!
CBD Pharma Co. MediPharm: 37% Increase In Q3 International Sales, 15% YoY Revenue Growth
CBD-based pharmaceutical company MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) announced on Thursday its third quarter financial results for the three months ended Sept. 30, 2024."Q3 2024 was a major step in the right direction towards profitability," Greg Hunter, the company's CFO, said. "Paying off our debt and rationalizing facilities, pursuing cost efficiencies while growing our higher margin international revenues are all critical elements to position us for long-term sustainable growth."
How Cannabis Is Changing Dementia Care For Patients And Families
Cannabis is emerging as a tool in dementia care, offering relief from anxiety and agitation when traditional medications fall short.
No Middleman, No Markup: How Red Mesa Is Slashing Costs With Around-The-Clock Hemp Refinement
By bypassing brokers and relying on an efficient, around-the-clock refinement process, Red Mesa aims to reduce costs and ensure consistency.
EXCLUSIVE: From Surviving Chavez's Venezuela To The CBD Crash - CEO Reveals How To Profit In A Market Stuck On Repeat
Jaunty's CEO Nicolas Guarino knows survival, having led his family through Venezuela's crisis before facing a 99% CBD market crash in the USA. Ever feel like the CBD market is on autopilot, stuck in a cycle of repetitive products and shrinking profit margins? For cannabis investors, this stuck-on-repeat dynamic has meant intense price pressure and dwindling returns.
New York's Surprise Ban On Cannabis-Caffeine Products Raises Eyebrows In Industry (UPDATED)
NY bans caffeine-infused cannabis products, prompting industry outcry and Hudson Cannabis appeal. Regulators cite health concerns.
Cannabis Oil For Insomnia Found To Have No Impact On Next-Day Cognitive Function
A new study shows medicinal cannabis oil used for insomnia does not impair cognitive function or driving the next day, suggesting safe therapeutic use.
From Vacation To Legal Nightmare: How A Georgia Veteran's CBD Arrest In Dubai Landed Him Behind Bars
A retired Georgia Navy veteran faces drug trafficking charges in Dubai after being arrested for possessing medically prescribed CBD pills.
Supreme Court Split Over Trucker Fired For Unintentional CBD Use, Suing Under RICO Act
U.S. Supreme Court considering RICO case involving fired truck driver claiming injury from CBD product, divided on implications of ruling.
CBD Nutraceuticals Market Set For Explosive Growth, Projected To Reach $29.1B By 2030
The global CBD nutraceuticals market is expected to reach $29.1 billion by 2030, driven by rising demand for plant-based health products and CBD innovations.
Cannabinoids Show Promising Anti-Cancer Potential Yet Mechanisms Remain Unclear, New Study
New study shows cannabinoids' potential in cancer treatment, but mechanisms remain unclear. Learn about the challenges and research gaps.
Women Face Criminal Charges Over Pregnancy For Medical Cannabis Use, Record Number Of Prosecutions In Year After Dobbs
Over two hundred pregnant people faced criminal charges for conduct related to pregnancy, abortion, pregnancy loss or birth during the first year following the Dobbs v. Jackson Women's Health Organization decision. Some women faced prosecution for using medical cannabis, despite being registered patients under state law. That's according to a report from Pregnancy Justice, a reproductive rights organization, titled "Pregnancy as a Crime: A Preliminary Report on the First Year After Dobbs." Following methamphetamines, cannabis was the second most common drug appearing in 86 of the total number of cases.
Congressional Bill Is Game-Changer For CBD Regulation, It's 'Long Overdue,' Says Hemp Coalition
Sen. Ron Wyden (D-OR) made headlines a week ago after introducing the Cannabinoid Safety and Regulation Act (CSRA), a measure that seeks to set up a federal framework for regulating hemp-derived cannabinoids like CBD and Delta-8 THC. On Wednesday, ONE HEMP hailed Congressional action toward the regulation of CBD as a dietary supplement, calling the move "long overdue." The coalition of industry leaders was committed to advancing regulatory standards for hemp-derived cannabinoid (CBD) products for years.
Synthetic Cannabinoids Could Be Federally Banned Under New Senate Bill To Regulate Hemp-Derived Products
New Senate bill aims to regulate hemp-derived products and ban synthetic cannabinoids like Delta-8 THC, impacting industry and consumers.
CBD's Toxicity Concerns: Could Europe Ban Cannabidiol In Cosmetics?
CBD could be deemed toxic for reproduction, which would then lead to its prohibition in cosmetic products across Europe.
Georgia Tightens Hemp Laws: New Restrictions On Age Limits, Edibles, Store Locations To Take Effect Oct. 1
Georgia's new hemp law takes effect on October 1, banning sales to under-21s and removing food-based CBD products.
CBD Suppositories Could Be A Game-Changer For Menstrual Relief, Harvard Study Shows
New research highlights how high-CBD vaginal suppositories can reduce menstrual pain, improve mood, and lower pain medication use.
Beer Industry Trade Association Endorses California Governor's Ban On Hemp-Derived THC
California Gov. Newsom's ban on hemp-derived THC gains support from a major beer industry trade association, amid hemp industry's opposition.
Aurora's CBD Lozenge Partnership: Here's Where To Find The New Product
Canadian medical cannabis company Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) and Vectura Fertin Pharma, Inc., an innovator in wellness and healthcare, announced on Monday the launch of the newly developed Luo CBD lozenge. The product was developed by Vectura Fertin Pharma, and represents the company's first medical cannabis CBD lozenge to be introduced in Canada.The move follows the announced commercial collaboration between Vectura Fertin Pharma's subsidiary Cogent International and the Edmonton, Alberta-based company to leverage Aurora's Canadian medical cannabis patient platform.
Mounting Research Supports Cannabis As Health Care Tool: Plant Compounds Relieve Endometriosis Pain And Reduce Fatigue, Studies Find
Two new studies highlight cannabis' benefits in reducing pain for endometriosis patients and CBD's role in easing daytime fatigue.
CBD Increases Effect Of THC, New Study Finds - Quite The Opposite Of Popular Belief
Clinical Pharmacology & Therapeutics that overturns the conventional view, revealing that CBD may actually increase the effects of THC
NASDAQ Cannabis Titan, Aurora, Could Boost 31% Sales Surge With This New CBD Lozenge Partnership
The cannabis company on Nasdaq has partnered with Vectura Fertin Pharma, to launch a dissolvable tablet that delivers a precise dose of CBD.
Will Cannabis Be A Game-Changer For Athletes? NFL's $1M Study Suggests It Could
The NFL and NCAA are rethinking their stance on cannabis, as groundbreaking research uncovers its potential benefits for athletes.
;

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2025 Benzinga | All Rights Reserved